All Boards & Shareholders articles – Page 12
-
Article
Solutions for fixing proxy process are often radically different
Nearly everyone agrees that the current system of shareholder voting should be improved. How to do that is a contentious debate as an SEC roundtable on the matter draws near.
-
Article
California first U.S. state to mandate women on boards
Boards of directors for California public companies will now need to ensure that they seat more women at the table.
-
Article
Three compliance lessons from Elon Musk’s SEC deal
Elon Musk, Tesla, and the SEC have agreed upon a settlement to resolve potential securities fraud perpetrated by an August tweet. Important lessons and reminders for compliance officers rise to the surface of that document.
-
Article
Withdrawal of past guidance signals a contentious start to SEC’s proxy process review
Critics of proxy advisory firms are cheering the withdrawal of 2004 no-action letters that they say empowered and entrenched the firms.
-
Podcast
Podcast: California considers board diversity rules
In this edition of the Compliance Week podcast, we discuss California’s SB-826, a bill mandating that major companies in the state put female directors on their boards. We spoke to Lillian Tsu, a partner at Hogan Lovells and member of the firms Public Company Advisory Practice for her views on ...
-
Article
Counterpoint: Crowds need to wise up
Public Citizen’s Bartlett Naylor advises careful consideration of current crowdfunding rules before considering a cap raise.
-
Article
Point: Benefits of crowdfunding
Attorney Douglas Ellenoff discusses why raising the crowdfunding cap boosts the fundraising method’s benefits.
-
Article
Shareholders seeking $10.6 billion from VW over emissions disclosure
Shareholders seeking damages worth €9.2 billion (U.S. $10.6 billion) have taken German car giant Volkswagen to court in Germany for failing to inform them fully of the financial impact that the emissions cheating scandal would have on the company’s share price.
-
Blog
Pay for outside corporate directors barely increased in 2017
Total pay for outside directors at the nation’s largest corporations increased by a mere 3 percent in 2017, driven by increases in cash and stock compensation, according to a new analysis by Willis Towers Watson.
-
Article
Hot and getting hotter in Tesla’s kitchen
The real discussion surrounding Tesla and the recent tweet from CEO Elon Musk is a much-needed debate about boards of directors.
-
Blog
Opioid crisis sparks leadership changes at Purdue Pharma
In an attempt to distance itself from the opioid epedemic, Purdue Pharma recently made some leadership changes to its board of directors and executive committee, as it battles hundreds of lawsuits across the United States concerning opioid-related deceptive sales and marketing practices that are the focus of U.S. enforcement authorities.
-
Blog
All eyes on the CBS board of directors
The role of the board of directors in a best practices compliance program takes on even more importance when senior management engages in recalcitrant conduct. It remains to be seen if the CBS board will step up in a time of crisis.
-
Blog
SEC plans roundtable on proxy access
The Securities and Exchange Commission will host a roundtable later this year to hear from investors, issuers, and other market participants about whether its proxy rules should be refined.
-
Article
Implementing the FRC’s ‘Guidance on the Strategic Report’
The Financial Reporting Council has published revised guidance addressing strategic reports, aiming to help organizations make such reports more informative and relevant to stakeholders.
-
Blog
Incorporating compliance into long-term corporate strategy
How can a board of directors work to incorporate the compliance function into a long-term business strategy of the organization? Tom Fox has a few ideas.
-
Blog
SEC allows shift from paper fund reports
The SEC voted unanimously Tuesday on initiatives to improve the experience of those who invest in mutual funds, ETFs and other investment funds.
-
Blog
Novartis lawyer quits amid Michael Cohen contract controversy
Swiss pharmaceutical giant Novartis announced May 16 that Group General Counsel Felix Ehrat is stepping down. His abrupt departure follows revelations that Novartis had a $1.2 million contract with President Donald Trump’s personal attorney Michael Cohen in exchange for access to the White House on healthcare policy.
-
Article
With proxy season under way, so is executive pay scrutiny
Although this year’s proxy season is just beginning, there are already some clues about how shareholders are voting on corporate pay packages.
-
Blog
Allergan elects new board member
Allergan has elected John Davidson to its board of directors. Davidson and the other directors standing for re-election to Allergan's board were elected at Allergan's Annual General Meeting of Shareholders on May 2.
-
Blog
NOVAGOLD announces election of directors
Novagold Resources, a precious metals company engaged in the development of mineral properties in North America, has announced the election of directors from its Annual General Meeting of Shareholders held on May 4.